• Novellus (NASDAQ:NVLS) CEO Rick Hill provided optimistic outlooks for the current quarter and next. He narrowed the gain in bookings to an expected 40-55% rise from 20-50%, the range of shipments to $150 -$170 million from $140-$170 million, with earnings expected to range between a nine cent loss and breakeven, up from a 15 cent loss and breakeven
• Citigroup (NYSE:C) analysts lowered their rating on Abercrombie and Fitch (NYSE:ANF) to "sell" from "hold" and cut the price target to $24 from $33
• Costco (NASDAQ:COST) received an upgrade from JP Morgan (NYSE:JPM)
• H&R Block (NYSE:HRB) reported fiscal first quarter loss from continuing operations of 39 cents a share, a bit worse than the Zacks expectations of a 37 cent loss, as revenues grew 1.3% to $275.5 million, off estimates of $281 million. The firm, however, maintained full year projections of $1.60-$1.80
• Cooper Companies (NYSE:COO) reported third quarter earnings of 54
...
Tags for this Post:Abercrombie and Fitch;,
Biogen Idec,
cent;,
ceo,
Citigroup,
Collective Brands,
Constellation Brands,
Cooper Companies,
costco,
Elan,
eln,
FBR Capital;,
Federal court;,
H&R Block,
Johnson & Johnson,
JP-Morgan,
Multiple Sclerosis,
Novellus,
Rick Hill,
Standard and Poor's Ratings Services,
Stocks to Watch,
Tysabri,
USD,
W.W. Grainger,
W.W. Grainger;,
Zacks Market Commentaries